441 related articles for article (PubMed ID: 4060827)
1. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
Borggrefe M; Breithardt G
Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
4. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
Kühlkamp V; Mewis C; Mayer F; Seipel L
Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
[TBL] [Abstract][Full Text] [Related]
5. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
Pfitzner P; Manz M; Schütz R; Lüderitz B
Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
[TBL] [Abstract][Full Text] [Related]
6. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
9. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
11. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
[TBL] [Abstract][Full Text] [Related]
13. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.
Chiou CW; Chen SA; Kung MH; Chang MS; Prystowsky EN
Circulation; 2003 May; 107(20):2583-8. PubMed ID: 12743004
[TBL] [Abstract][Full Text] [Related]
14. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Yee R
Anesthesiology; 1995 Apr; 82(4):888-95. PubMed ID: 7717560
[TBL] [Abstract][Full Text] [Related]
15. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
[TBL] [Abstract][Full Text] [Related]
16. Sotalol in patients with Wolff-Parkinson-White syndrome.
Kunze KP; Schlüter M; Kuck KH
Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
[TBL] [Abstract][Full Text] [Related]
17. Tachycardia cycle length and maximum capacity of anterograde and retrograde atrioventricular conduction in paroxysmal supraventricular tachycardia.
Sadr-Ameli MA; Lacombe P; Fromer M; Nadeau R; Shenasa M
Can J Cardiol; 1988 Apr; 4(3):134-9. PubMed ID: 3378196
[TBL] [Abstract][Full Text] [Related]
18. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
19. [Effects of oral sotalol on the conduction of accessory atrioventricular pathways].
Blanc JJ; Boschat J; Ollivier JP; Penther P
Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1097-102. PubMed ID: 3929739
[TBL] [Abstract][Full Text] [Related]
20. Surgical therapy for patients with supraventricular tachycardia.
Ferguson TB; Cox JL
Cardiol Clin; 1990 Aug; 8(3):535-55. PubMed ID: 2205389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
